RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more
NTT DATA Business Solutions AG
apoplex medical technologies GmbH
NTT DATA Business Solutions AG
Fraunhofer-Institut für Sichere Informationstechnologie SIT
dpa Deutsche Presse-Agentur GmbH
dpa Deutsche Presse-Agentur GmbH
NTT DATA Business Solutions AG